Repros Therapeutics Inc.
RPRX
RPRX was delisted on the 31st of January, 2018.
75 hedge funds and large institutions have $199M invested in Repros Therapeutics Inc. in 2014 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 27 increasing their positions, 18 reducing their positions, and 19 closing their positions.
79% more call options, than puts
Call options by funds: $10.8M | Put options by funds: $6.02M
50% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 18
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
3% less funds holding
Funds holding: 77 → 75 (-2)
11% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 19
48% less capital invested
Capital invested by funds: $379M → $199M (-$180M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$21.7M |
| 2 |
PC
Paulson & Co
New York
|
+$14.8M |
| 3 |
Millennium Management
New York
|
+$12.2M |
| 4 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
+$11.5M |
| 5 |
SAM
Senzar Asset Management
New York
|
+$11.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
-$45.2M |
| 2 |
VAM
Visium Asset Management
New York
|
-$21.5M |
| 3 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$21.1M |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$14.7M |
| 5 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
-$13.7M |
RPRX Hedge Fund Activity: Q3 2014 in Review
75 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Repros Therapeutics Inc. (RPRX) for Q3 2014, worth a combined $199M — down 48% from $379M a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of RPRX and 17 opened new positions — a net loss of 2 holders — while 18 trimmed existing stakes and 27 added.
The largest buyer was Fidelity Investments, adding an estimated $21.7M. The largest seller was Franklin Resources, exiting entirely with an estimated $45.2M sold.
- 75 institutional investors held Repros Therapeutics Inc. (RPRX) as of Q3 2014, down from 77 in Q2 2014.
- Funds reported $199M of Repros Therapeutics Inc. stock for Q3 2014, down 48% quarter-over-quarter.
- 17 funds opened new Repros Therapeutics Inc. positions in Q3 2014 and 19 closed out, a net change of -2 holders.
- The largest Repros Therapeutics Inc. buyer in Q3 2014 was Fidelity Investments, an estimated $21.7M added.
- The largest Repros Therapeutics Inc. seller in Q3 2014 was Franklin Resources, an estimated $45.2M sold.
Based on aggregated 13F filings for Q3 2014.